October 6-7, 2025 | Paris, France

International Conference on

Antiviral Therapy and Drug Development- 2025

Theme: “From Discovery to Deployment: Streamlining Antiviral Drug Development”

Innovation-Driven Research

General Info

About Us

Important Dates

General Info

About Us

Important Dates

Speakers

ABCD 4

To know more about our conferences and events do get in touch with us and join our large network of scientists, professional experts, and research scholars.

ABCD 3

To know more about our conferences and events do get in touch with us and join our large network of scientists, professional experts, and research scholars.

ABCD 2

To know more about our conferences and events do get in touch with us and join our large network of scientists, professional experts, and research scholars.

ABCD 1

To know more about our conferences and events do get in touch with us and join our large network of scientists, professional experts, and research scholars.

Scientific Sessions/Topics

Bacterial Infectious Diseases

Bacterial infectious diseases are caused by pathogenic bacteria and remain a global health challenge. These diseases, like tuberculosis, cholera, and pneumonia, spread through direct contact or contaminated environments. Understanding bacterial mechanisms, including resistance, is critical for developing treatments. At the **Vaccines Conference**, experts discussed strategies for vaccine development to combat these bacterial infections and improve global health outcomes.

Upcoming Evernts

Keys Topics

Drug Development and Virology Conference | Antiviral Therapeutics Meeting | Antiviral Research Conference | Antiviral Drug Conference

Parasitology & Infectious Diseases

At the Antiviral Therapy Conference, discussions on parasitology & infectious diseases highlighted the global burden caused by parasitic infections like malaria, leishmaniasis, and Chagas disease. Experts explored how advancements in antiviral and antiparasitic therapies, along with innovative vaccine development, are critical for combating these diseases and improving treatment strategies, especially in regions with high infection rates.

Upcoming Evernts

Vaccines and Vaccination

At the Antiviral Treatment Conference, specialists underscored the vital job of vaccines and vaccination in forestalling viral contaminations. Conversations zeroed in on how immunizations supplement antiviral treatments by supporting resistance, forestalling the spread of illnesses like flu, measles, and Coronavirus. The gathering likewise investigated headways in antibody advances, like mRNA and viral vectors, to upgrade worldwide immunization endeavors and safeguard against arising viral dangers.

Nosocomial Infections & Control

At Nosocomial Infections: Control Measures, a discussion focused on nosocomial infections and their adequate control measures at the **Antiviral Therapy Conference**. Hospital-acquired infections, usually by resistant pathogens, constitute one of the major important sources of severe pressure in health care environments. Experts reviewed the prevention strategies through improved hygiene, infections’ control, and the role of antiviral therapy in managing these infections and decreasing nosocomial infections in hospitals and clinics.

Veterinary Diseases

Veterinary diseases were elucidated by the **Conference of Antiviral Therapy** experts in their impact on both animals and human health. This includes avian influenza and rabies, such as other zoonotic diseases, to make the importance of antiviral therapies in veterinary medicine evident. Conferences are also continuously held underlining the significance of vaccine development and treatments which control infections in animals and thus avert cross-species transmission for public health.

Fungal Infectious Diseases

At the **Antiviral Therapy Conference**, discussions on **fungal infectious diseases** highlighted the rising threat of infections like candidiasis, aspergillosis, and cryptococcosis, especially in immunocompromised patients. Experts examined the challenges in treatment, focusing on the need for novel antifungal therapies alongside antivirals, improving diagnostics, and advancing prevention strategies to combat these life-threatening infections.

STD and HIV Infection

At the **Antiviral Therapeutics Meeting**, STD and HIV infections were discussed: considerable advancements in antiviral therapy. Such comprises early intervention, prevention, and new drug classes comprising long-acting antivirals and combinations as a means for improving patient outcomes, lowering transmission rates, and managing resistance for the control of sexually transmitted infections and HIV.

Upcoming Evernts

Neuro Infectious Diseases

Topics of the discussion at the **Antiviral Therapeutics Meeting** were prominently centered around **neuro infectious diseases**, such as viral encephalitis, meningitis, and neuro-HIV. The experts stressed that there is a critical void for effective antiviral agents targeting the central nervous system to minimize these terrible infections. Discussion was made regarding the advancement in therapy development – drugs crossing the blood-brain barrier to improve the treatment regimen and outcome for patients whose lives are devastated by this dangerous infection.

Upcoming Evernts

Market Analysis of Infectious Diseases

At the **Antiviral Therapeutics Meeting**, the **market analysis of infectious diseases** highlighted the growing demand for antiviral drugs due to rising infections like COVID-19, HIV, and hepatitis. Experts discussed the expanding market for antiviral therapies, driven by innovations in drug development, increased global healthcare spending, and the need for effective treatments to address resistant strains and emerging infectious threats.

Problems in Infectious Disease Practice

At the **Antiviral Therapeutics Meeting**, experts discussed key **problems in infectious disease practice**, including rising drug resistance, limited access to new antivirals, and diagnostic challenges. The emergence of new viral strains, inadequate global healthcare infrastructure, and treatment affordability were identified as critical barriers in effective management and control of infectious diseases, necessitating ongoing innovation and collaboration in antiviral therapy development.

Sepsis/Septicemia

At the **Antiviral Research Conference**, discussions on sepsis/septicemia practice at the conference focused on the interactive complexity between viral infections and sepsis. It is crucial to highlight early diagnosis and early treatment of viral pathogens which lead to septicemia to form precious steps in the improvement of the outcome for the patient. These begin from the crucial targeted antiviral therapies and supportive care measures.

Pediatric Infectious Diseases

At the **Conference on Antiviral Research**, the concentration has been made to pay lots of attention to pediatric infectious diseases, especially the challenges of treating viral infections in children. A subject of discussion with experts must include the age-specific approach in antiviral therapy and the importance of immunization in diseases such as influenza and RSV. It should emphasize finding new medicines for new viruses, whichever way they are actual or potential, specially tailored for the pediatric population, thus providing better care and better health outcomes.

Please provide a concise overview of your proposed talk, presentation, symposium, or workshop that aligns with your session interest, including key themes and objectives.

Related Conferences

REGISTRATION

Speaker

Early Bird Registration

$745

Student

Early Bird

$395

Delegate

Early Bird

$795

Get In Touch

To learn more about our conferences and events, please get in touch with us. Join our extensive network of scientists, professional experts, and research scholars to stay informed and connected.

Address

16192 Coastal Highway Lewes, Delaware, USA 19958

Phone number

+1 630 768 1199

E-mail address

support@stripeconferences.com

Media Partners

Venue

Paris, the capital of France, is an energetic city known for its rich social and logical legacy. Home to eminent establishments, for example, the Sorbonne and the CNRS, Paris encourages a climate of development and cooperation. The city is renowned for its notorious tourist spots, including the Eiffel Pinnacle and the Louver, which mirror its authentic importance. With its enchanting areas, a-list food, and dynamic expressions scene, Paris gives a motivating setting to logical meetings, empowering productive conversations and associations among scientists and experts from around the globe.

FAQ's

What is the primary focus of the Antiviral Drug Conference?

The gathering will zero in on the most recent progressions in antiviral medication improvement, including novel treatments, systems of activity, and procedures for battling viral contaminations like HIV, hepatitis, and arising infections.

Who should attend the Antiviral Drug Conference?

This conference is ideal for researchers, pharmaceutical professionals, healthcare providers, and public health officials interested in antiviral drug research, development, and clinical applications.

Will there be discussions on drug resistance and its implications?

Indeed, the gathering will address the difficulties of medication opposition in viral diseases, investigating procedures to foster powerful antiviral medicines and the significance of checking obstruction designs.

Are networking opportunities available during the conference?

Totally! The Antiviral Medication Gathering will give different systems administration meetings, studios, and board conversations to encourage cooperation and information dividing between participants.

How can I stay updated on the conference details?

To get refreshes on speakers, enlistment, and other significant data, buy into our bulletin and follow our authority virtual entertainment feeds for the most recent declarations with respect to the Antiviral Medication Meeting.

CONTACT US

Error: Contact form not found.